DVAX
Dynavax Technologies Corp
Price:  
12.76 
USD
Volume:  
1,489,835.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

DVAX EV/EBITDA

-125.7%
Upside

As of 2024-03-03, the EV/EBITDA ratio of Dynavax Technologies Corp (DVAX) is -77.84. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. DVAX's latest enterprise value is 1,739.00 mil USD. DVAX's TTM EBITDA according to its financial statements is -22.34 mil USD. Dividing these 2 quantities gives us the above DVAX EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 13.2x - 17.8x 13.9x
Forward P/E multiples 17.1x - 21.2x 17.9x
Fair Price (3.47) - (3.60) (3.27)
Upside -127.2% - -128.2% -125.7%
12.76 USD
Stock Price
(3.27) USD
Fair Price

DVAX EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-03-01 -77.84
2024-02-29 -77.32
2024-02-28 -78.95
2024-02-27 -79.19
2024-02-26 -80.06
2024-02-23 -77.78
2024-02-22 -75.97
2024-02-21 -76.09
2024-02-20 -75.04
2024-02-16 -75.80
2024-02-15 -76.21
2024-02-14 -76.21
2024-02-13 -75.09
2024-02-12 -78.19
2024-02-09 -78.78
2024-02-08 -78.54
2024-02-07 -78.66
2024-02-06 -79.13
2024-02-05 -78.02
2024-02-02 -77.78
2024-02-01 -77.96
2024-01-31 -78.78
2024-01-30 -79.48
2024-01-29 -81.58
2024-01-26 -81.12
2024-01-25 -83.63
2024-01-24 -84.74
2024-01-23 -86.61
2024-01-22 -86.14
2024-01-19 -84.80
2024-01-18 -84.92
2024-01-17 -85.03
2024-01-16 -86.14
2024-01-12 -84.68
2024-01-11 -84.45
2024-01-10 -83.98
2024-01-09 -84.57
2024-01-08 -84.92
2024-01-05 -89.42
2024-01-04 -90.82
2024-01-03 -87.55
2024-01-02 -87.31
2023-12-29 -84.98
2023-12-28 -86.44
2023-12-27 -85.85
2023-12-26 -85.27
2023-12-22 -84.16
2023-12-21 -82.87
2023-12-20 -80.77
2023-12-19 -84.10